ARCHIVES

Highlights of NCDDGs: 3 Drugs on Market, 12 in Development; Advisors Approve Plan to Issue $10.5 Million Contract For Pediatric Preclinical Testing Program

This article is from The Cancer Letter archive.

Vol. 28 No. 44 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

Fred Conrad, MDA VP, Shot To Death In Hospital Office

January 7, 1983

Guest Editorial: MD Anderson’s Judith Smith Questions NCI Short-Term Remedy For Carboplatin Dosing

October 15, 2010

The View Forom The White House On Research Funding

August 16, 1991

In Brief: Control Grant Review committee Out Of Grants Division Provisional Training Announcement Due

October 10, 1975

Large Study Finds No Survival Benefit Associated With Removal Of Ovaries

January 30, 2009

NCAB Subcommittee Works On Drafting Quantitative Risk Assessment Policy

October 1, 1982